TITLE

Dalteparin reduced venous thromboembolic events without increased bleeding in acutely ill medical patients

AUTHOR(S)
von Garnier, Christophe; Ryan, Gerard; Douketis, James
PUB. DATE
July 2005
SOURCE
ACP Journal Club;Jul/Aug2005, Vol. 143 Issue 1, p59
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
Presents several letters to the editor focusing on various topics and issues discussed in previous issues of the periodical. Discussion of the evidence for clinical decisions; Fact that routine prophylactic anticoagulation for medical patients is an issue of great importance to physicians; Report that all medical patients should receive anticoagulant prophylaxis for deep venous thrombosis.
ACCESSION #
18053709

 

Related Articles

  • Prognostic Factors in Noncirrhotic Patients With Splanchnic Vein Thromboses. Amitrano, Lucio; Guardascione, Maria Anna; Scaglione, Mariano; Pezzullo, Luca; Sangiuliano, Nicola; Armellino, Mariano F.; Manguso, Francesco; Margaglione, Maurizio; Ames, Paul R. J.; Iannaccone, Luigi; Grandone, Elvira; Romano, Luigia; Balzano, Antonio // American Journal of Gastroenterology;Nov2007, Vol. 102 Issue 11, p2464 

    OBJECTIVES AND METHODS: Splanchnic vein thrombosis (SVT), not associated with cancer or liver cirrhosis, is a rare event and scanty data are available on its natural history, long-term prognosis, and treatment. In this study 121 SVT patients consecutively seen from January 1998 to December 2005...

  • Shunt Thrombosis Prevention in Hemodialysis Patients -- A Double-Blind, Randomized Study: Pentoxifylline vs Placebo. Radmilović, A.; Borić, Z.; Naumović, T.; Stamenković, M.; Muśikić, P. // Angiology;Jul1987, Vol. 38 Issue 7, p499 

    Previous studies demonstrated a high incidence of local thrombosis in patients in whom external arteriovenous shunts were used for vascular access. This procedure provides, therefore, a useful model for the evaluation of potential antithrombotic agents. The effect of the hemorheologically and...

  • Managements for lateral sinus thrombosis: does it need the ligation of internal jugular vein or anticoagulants? Jun Ho Lee; Seong Jun Choi; Keehyun Park; Yun-Hoon Choung // European Archives of Oto-Rhino-Laryngology;Jan2009, Vol. 266 Issue 1, p51 

    The purposes of this study were to review the clinical characteristics and treatment outcomes of patients with lateral sinus thrombosis (LST) and to discuss the need of internal jugular vein (IJV) ligation or anticoagulants. We retrospectively reviewed the charts of five patients (1 male and 4...

  • Incidence of thrombophilia detected in southern Taiwanese patients with venous thrombosis. Chen, T.-Y.; Su, W.-C.; Tsao, C.-J. // Annals of Hematology;Feb2003, Vol. 82 Issue 2, p114 

    In order to analyze the incidence of thrombophilia in southern Taiwan, we studied the prevalence of antithrombin (AT), protein C (PC), and protein S (PS) deficiencies, the prevalence of factor V Leiden mutation, and the presence of acquired lupus anticoagulant (LA) and anticardiolipin antibody...

  • HOME TREATMENT OF DEEP VENOUS THROMBOSIS. Force, Rex W. // Journal of Family Practice;Jun1996, Vol. 42 Issue 6, p566 

    The article discusses research being done on the treatment of deep venous thrombosis (DVT). It references a study by M. Levine et al published in the 1996 issue of the "New England Journal of Medicine." Low-molecular-weight heparins (LMWH) are given for the prevention of deep vein thrombosis....

  • Ximelagatran—Promises and Concerns. Gurewich, Victor // JAMA: Journal of the American Medical Association;2/9/2005, Vol. 293 Issue 6, p736 

    Presents an editorial on the several studies in this issue looking at the use of ximelagatran in the treatment of thrombosis. Background on anticoagulant use; Inherent problems with warfarin treatment; Hospitalization rate of patients on vitamin K antagonists; How ximelagatran works within the...

  • Mechanisms of Thrombus Formation. Furie, Bruce; Furie, Barbara C. // New England Journal of Medicine;8/28/2008, Vol. 359 Issue 9, p938 

    The article presents an overview of the factors which lead to the formation of a platelet thrombus. A discussion of research which has looked at thrombus formation, and of the role blood coagulation, thrombin, fibrin and tissue factor play in thrombus formation, is presented. Cancer associated...

  • CONTROL OF ANTICOAGULANT THERAPY IN HOSPITAL. Hutton, I.; Reid, D.S.; Linton, A.L. // Angiology;May1966, Vol. 17 Issue 5, p292 

    An attempt has been made to assess the degree of control achieved during short term anticoagulant therapy as prescribed by one house physician. Less than 50 per cent of the patients treated proved to be well controlled, and the difficulties encountered are described. It is possible that...

  • Dabigatran for Anticoagulation in Atrial Fibrillation – Early Clinical Experience in a Hospital Population and Comparison to Trial Data Michel, Jonathan; Mundell, David; Boga, Tau; Sasse, Alexander // Heart, Lung & Circulation;Jan2013, Vol. 22 Issue 1, p50 

    Background: Dabigatran is a recently introduced direct thrombin inhibitor licensed for use as an oral anticoagulant for stroke prevention in non-valvular atrial fibrillation. Our prospective observational study aimed to assess the adverse effects, tolerability and patient satisfaction of...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics